Recent progress in advanced biomaterials for long-acting reversible contraception

J Nanobiotechnology. 2022 Mar 17;20(1):138. doi: 10.1186/s12951-022-01329-5.

Abstract

Unintended pregnancy is a global issue with serious ramifications for women, their families, and society, including abortion, infertility, and maternal death. Although existing contraceptive strategies have been widely used in people's lives, there have not been satisfactory feedbacks due to low contraceptive efficacy and related side effects (e.g., decreased sexuality, menstrual cycle disorder, and even lifelong infertility). In recent years, biomaterials-based long-acting reversible contraception has received increasing attention from the viewpoint of fundamental research and practical applications mainly owing to improved delivery routes and controlled drug delivery. This review summarizes recent progress in advanced biomaterials for long-acting reversible contraception via various delivery routes, including subcutaneous implant, transdermal patch, oral administration, vaginal ring, intrauterine device, fallopian tube occlusion, vas deferens contraception, and Intravenous administration. In addition, biomaterials, especially nanomaterials, still need to be improved and prospects for the future in contraception are mentioned.

Keywords: Biodegradable implant; Biomaterials; Controlled drug delivery; Delivery route; Long-acting reversible contraception.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials
  • Contraception
  • Contraceptive Agents, Female* / therapeutic use
  • Female
  • Humans
  • Intrauterine Devices*
  • Long-Acting Reversible Contraception*
  • Pregnancy

Substances

  • Biocompatible Materials
  • Contraceptive Agents, Female